Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antineoplastic Agents > Topiroxostat for Sale > 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - large image1
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image1
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image2
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image3
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image4
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image5
4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile buy - image6

4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile

4 Inquiries

Unit Price: Get Latest Price
CAS No.:

577778-58-6

Grade:

Industrial Grade

Content:

99%

Port:

beijing

Brand:

SHANDONG BOYUAN

Packaging:

25kg

Price valid (until):

2024-08-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    FYX051;Topiroxostat;Topiroxostat,FYX-051;5-(2-Cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole;Topiroxostat5-(2-Cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazolChemicalbooke;4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile;2-Pyridinecarbonitrile,4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-;Topiroxostatimpurty

    Introduction Topiroxostat (FYX-051), chemical name 5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole, is made of A non-purine selective xanthine oxidoreductase inhibitor that selectively and reversibly inhibits xanthine oxidoreductase and reduces serum uric acid value researched and developed by Fuji Pharmaceutical Co., Ltd. of Japan. Action: Topirastat competitively inhibits purine oxidoreductase, thereby inhibiting the production of uric acid. It has no blocking effect on other pyrimidine-purine metabolism enzymes, but shows selective blocking effect on xanthine oxidoreductase. Topinostat has a significant inhibitory effect on both oxidized and reduced XOR, so its uric acid-lowering effect is more powerful and lasting. Therefore, this product can be used to treat chronic hyperuricemia in gout. Indications apply to gout and hyperuricemia.

    Topiroxostat (FYX-051), chemical name 5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazoleChemicalbook, is produced by A non-purine selective xanthine oxidoreductase inhibitor that selectively and reversibly inhibits xanthine oxidoreductase and reduces serum uric acid value researched and developed by Fuji Pharmaceutical Co., Ltd. of Japan.

    Items Specifications
    solubility DMSO : 23.5 mg/mL (94.67 mM; Need ultrasonic and warming)
    InChI InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)
    STORAGE Store at -20°C
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 1
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 2
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 3
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 4
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 5
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 6
    Shop 4-[5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile-Detailed Image 7

    Basic Info
    Product Name:

    Topiroxostat

    Other Name:

    2-Pyridinecarbonitrile,4-[3-(4-pyridinyl)-1H-1,2,4-triazol-5-yl]-;2-Pyridinecarbonitrile,4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-;4-[3-(4-Pyridinyl)-1H-1,2,4-triazol-5-yl]-2-pyridinecarbonitrile;5-(2-Cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole;FYX 051;Topiroxostat

    CAS No.:

    577778-58-6

    Molecular Formula:

    C13H8N6

    InChIKeys:

    InChIKey=UBVZQGOVTLIHLH-UHFFFAOYSA-N

    Molecular Weight:

    248.249

    Exact Mass:

    248.24

    UNII:

    0J877412JV

    DSSTox ID:

    DTXSID80206462

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    91.1

    XLogP3:

    1.2

    Density:

    1.5±0.1 g/cm3

    Boiling Point:

    594.7±60.0°C at 760 mmHg

    Flash Point:

    175.3±18.1 °C

    Refractive Index:

    1.697

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib

    Location:

    NO.28 SangYuan Rd,JinanCity,ShanDong Province,China

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    501-1000

    Year of Establishment:

    2005

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Topiroxostat

    10 G Jan 21, 2024
    India

    Topiroxostat

    Mar 12, 2024
    India

    Topiroxostat

    1 G Dec 15, 2023
    India

    topiroxostat

    10 G Sep 26, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.